We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+1.4%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$148B
AUM Growth
+$8.19B
Cap. Flow
+$6.46B
Cap. Flow %
4.35%
Top 10 Hldgs %
18.71%
Holding
2,935
New
79
Increased
1,853
Reduced
707
Closed
50

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$495M
2
MSFT icon
Microsoft
MSFT
+$480M
3
GPN icon
Global Payments
GPN
+$400M
4
MA icon
Mastercard
MA
+$274M
5
CMCSA icon
Comcast
CMCSA
+$254M

Sector Composition

Rank Sector Weight
1 Technology 18.77%
2 Financials 14.07%
3 Healthcare 13.13%
4 Consumer Discretionary 12.1%
5 Communication Services 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTT icon
2626
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
$98.2K ﹤0.01%
4,149
FMS icon
2627
Fresenius Medical Care
FMS
$13.8B
$96.8K ﹤0.01%
2,882
-114
-4% -$4.04K
ECOM
2628
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$96.5K ﹤0.01%
+10,341
New +$95K
ACOR
2629
DELISTED
Acorda Therapeutics
ACOR
$95.8K ﹤0.01%
278
+26
+10% +$14.1K
BNS icon
2630
Scotiabank
BNS
$107B
$94.9K ﹤0.01%
1,670
DBEU icon
2631
Xtrackers MSCI Europe Hedged Equity ETF
DBEU
$775M
$94.7K ﹤0.01%
3,174
-673
-17% -$19.6K
AMRS
2632
DELISTED
Amyris Inc.
AMRS
$94.6K ﹤0.01%
19,878
+3,778
+23% +$14.1K
EIGI
2633
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$91.3K ﹤0.01%
24,348
+8,574
+54% +$40.8K
ILCG icon
2634
iShares Morningstar Growth ETF
ILCG
$3.08B
$90K ﹤0.01%
2,350
DON icon
2635
WisdomTree US MidCap Dividend Fund
DON
$4.04B
$89.8K ﹤0.01%
2,472
NVEC icon
2636
NVE Corp
NVEC
$555M
$89K ﹤0.01%
1,341
-104
-7% -$7.08K
AUPH icon
2637
Aurinia Pharmaceuticals
AUPH
$1.93B
$87.9K ﹤0.01%
16,459
+3,159
+24% +$19.1K
SID icon
2638
Companhia Siderúrgica Nacional
SID
$1.34B
$86.9K ﹤0.01%
27,500
VNTR
2639
DELISTED
Venator Materials PLC
VNTR
$86.5K ﹤0.01%
35,450
+1,499
+4% +$4.77K
IGIB icon
2640
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.5B
$83.9K ﹤0.01%
1,448
VEON icon
2641
VEON
VEON
$3.66B
$83.5K ﹤0.01%
1,392
-8,128
-85% -$557K
BN icon
2642
Brookfield
BN
$103B
$83.1K ﹤0.01%
4,386
HSBC icon
2643
HSBC
HSBC
$367B
$82.9K ﹤0.01%
2,167
-26
-1% -$1.01K
IJT icon
2644
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.27B
$81.9K ﹤0.01%
918
BEST
2645
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$81.8K ﹤0.01%
775
RUBY
2646
DELISTED
Rubius Therapeutics, Inc
RUBY
$80.9K ﹤0.01%
10,300
DXJ icon
2647
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
$78.7K ﹤0.01%
1,559
-303
-16% -$14.7K
ROAN
2648
DELISTED
Roan Resources, Inc.
ROAN
$74.2K ﹤0.01%
+60,299
New +$78.5K
DGRW icon
2649
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$16.6B
$74K ﹤0.01%
1,642
-1,908
-54% -$84.4K
UGP icon
2650
Ultrapar
UGP
$6.9B
$73.7K ﹤0.01%
16,488

Similar funds

UBS AM's Q3 2019 Portfolio in Review

As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $167M trimmed.

  • UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
  • UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
  • UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
  • UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
  • UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
  • UBS AM opened 79 new positions and closed 50 in Q3 2019.
  • UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.

Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.